Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2023 Results and Participation in Upcoming Investor Conference
26 Outubro 2023 - 5:30PM
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the
development and commercialization of transformational technologies
for the treatment cardiovascular disease, will report financial
results for the third quarter 2023 after market close on Monday,
November 6, 2023. Company management will host a corresponding
conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m.
Eastern Time.
On Wednesday, November 15, 2023, at 8:45 a.m. Eastern Time,
Shockwave Medical management is scheduled to present at the 5th
Annual Wolfe Research Healthcare Conference, which is taking place
from Tuesday, November 14 - Wednesday, November 15, 2023, in New
York, NY.
Interested parties may access live and archived webcasts of
these events on the "Investors" section of the company’s website at
https://ir.shockwavemedical.com. Investors interested in dialing in
to the third quarter 2023 Shockwave Medical earnings conference
call on Monday November 6, 2023, at 1:30 p.m. Pacific Time / 4:30
p.m. Eastern Time may do so by dialing 877-704-4453 for domestic
callers or 201-389-0920 for international callers, using conference
ID: 13737257.
About Shockwave Medical, Inc.
Shockwave Medical is a leader in the development and
commercialization of innovative products that are transforming the
treatment of cardiovascular disease. Its first-of-its-kind
Intravascular Lithotripsy (IVL) technology has transformed the
treatment of atherosclerotic cardiovascular disease by safely using
sonic pressure waves to disrupt challenging calcified plaque,
resulting in significantly improved patient outcomes. Shockwave has
also recently acquired the Neovasc Reducer, which is under clinical
investigation in the United States and is CE Marked in the European
Union and the United Kingdom. By redistributing blood flow within
the heart, the Reducer is designed to provide relief to the
millions of patients worldwide suffering from refractory angina.
Learn more at www.shockwavemedical.com and www.neovasc.com.
Media Contact: Scott Shadiow
+1.317.432.9210sshadiow@shockwavemedical.com
Investor Contact:Debbie Kasterinvestors@shockwavemedical.com
Shockwave Medical (NASDAQ:SWAV)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Shockwave Medical (NASDAQ:SWAV)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024